$0.860300
-0.02-2.24%
Pre-Market: Jul 19, 7:40 PM EDT
15 minutes delayed
MiNK Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of MiNK Therapeutics using advanced sorting and filters.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
INKT | MiNK Therapeutics | -$0.18 | -$0.10 | — | — | $0.00 | — | — | — | 08/08/2024 | Get Alert |
INKT | MiNK Therapeutics | -$0.17 | -$0.15 | -$0.11 | 26.67% | $0.00 | — | $0.00 | — | 05/14/2024 | Get Alert |
INKT | MiNK Therapeutics | -$0.23 | -$0.15 | -$0.16 | -6.67% | $0.00 | — | $0.00 | — | 03/21/2024 | Get Alert |
INKT | MiNK Therapeutics | -$0.19 | -$0.18 | -$0.15 | 16.67% | $0.00 | — | $0.00 | — | 11/09/2023 | Get Alert |
INKT | MiNK Therapeutics | -$0.18 | -$0.20 | -$0.18 | 10.00% | $0.00 | — | $0.00 | — | 08/10/2023 | Get Alert |
INKT | MiNK Therapeutics | -$0.23 | -$0.24 | -$0.17 | 29.17% | $0.00 | — | $0.00 | — | 05/11/2023 | Get Alert |
INKT | MiNK Therapeutics | -$0.18 | -$0.21 | -$0.23 | -9.52% | $0.00 | — | $0.00 | — | 03/21/2023 | Get Alert |
INKT | MiNK Therapeutics | -$0.59 | -$0.23 | -$0.19 | 17.39% | $0.00 | — | $0.00 | — | 11/03/2022 | Get Alert |
INKT | MiNK Therapeutics | -$0.26 | -$0.24 | -$0.18 | 25.00% | $0.00 | — | $0.00 | — | 08/09/2022 | Get Alert |
INKT | MiNK Therapeutics | -$0.16 | -$0.21 | -$0.23 | -9.52% | $0.00 | — | $0.00 | — | 05/10/2022 | Get Alert |
INKT | MiNK Therapeutics | -$0.06 | — | -$0.18 | — | $0.00 | — | $0.00 | — | 03/18/2022 | Get Alert |
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Mar 2024 | 2024-05-14 | $-0.11 | $-0.15 | 26.7 % |
Dec 2023 | 2024-03-21 | $-0.16 | $-0.15 | -6.67 % |
Sep 2023 | 2023-11-09 | $-0.15 | $-0.18 | 16.7 % |
Jun 2023 | 2023-08-10 | $-0.18 | $-0.20 | 10.0 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
MiNK Therapeutics (INKT) is scheduled to report earnings on August 8, 2024. The last reported earnings were for reported on May 14, 2024 for Q1.
The Actual EPS was $-0.11, which beat the estimate of $-0.15.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.